Home › Neuroblastoma › Connecticut
Pag-aaral pangklinika para sa Neuroblastoma sa Connecticut
9 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa Connecticut.
Mga Lungsod sa Connecticut
Opisyal na teksto ng pag-aaral (English)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Connecticut Children's Medical Center, Hartford
Nagre-recruit
Hanggang edad 17 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06831552Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Connecticut Children's Hospital, Hartford
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06541262Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Yale New Haven Hospital ( Site 1012), New Haven
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Connecticut Children's Hospital, Hartford
Nagre-recruitPhase 2
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Connecticut Children's Hospital, Hartford
Nagre-recruitPhase 2
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Connecticut Children's Hospital, Hartford
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
Nagre-recruitPhase 3
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Connecticut Children's Hospital, Hartford
Nagre-recruitPhase 2
12 Months – 21 Years · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05489887Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.